Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Bone densitometry unproven says UK Centre for Reviews and Dissemination (CRD)

This article was originally published in Clinica

Executive Summary

The case for bone densitometry in clinical practice is not yet proven, says Trevor Sheldon, Director of the NHS Centre for Reviews and Dissemination. Writing in response to a review published in the BMJ in June, he says the authors provide no evidence to show that clinical decision-making in high-risk cases is influenced by the technique. The presence of multiple risk factors is more important in predicting hip fractures in older white women, he writes in a letter to the BMJ (September 9th).

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT093285

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel